(NASDAQ: DYAI) Dyadic International's forecast annual revenue growth rate of 136.33% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Dyadic International's revenue in 2024 is $2,898,806.On average, 2 Wall Street analysts forecast DYAI's revenue for 2024 to be $124,588,652, with the lowest DYAI revenue forecast at $121,691,241, and the highest DYAI revenue forecast at $127,486,062.
In 2025, DYAI is forecast to generate $176,742,041 in revenue, with the lowest revenue forecast at $176,742,041 and the highest revenue forecast at $176,742,041.